Study

EORTC-1750-QLG

Update of the EORTC QLQ-MY20 questionnaire for the assessment of quality of life in Multiple Myeloma patients. Phase I-III Study on behalf of the EORTC Quality of Life Group

Study documentation Back to result

Trial Status

Recruiting

Dates

Data management at EORTC

None

Design

QoL Module development
Not randomized / N.A.

Treatment

None

Study Staff

  • Charalampia Kyriakou (Study Coordinator), University College Hospital, London
  • Melanie Beauvois (Clinical Operations Manager), EORTC Headquarters, Brussels

Type of cancer

  • Multiple Myeloma

Participating groups

  • EORTC Quality of Life Group